Clinical Trials Browser

Phase 2 × Interventional × Germinoma × Clear all

Diabetes Insipidus, Germinoma

NCT03158064 2026-01-28

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Phase 2 Active not recruiting

30 enrolled

Nonseminomatous germ cell tumor, Dysgerminoma, Neoplasms, Germ Cell and Embryonal, Germinoma, Seminoma

NCT06418789 2025-08-03

GERMAN

Phase 2 Recruiting

25 enrolled

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

NCT01966809 2019-08-20

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Phase 2 Terminated

1 enrolled 5 charts

CNSEndocrineSarcoma

Astrocytoma, Brain Neoplasms, Chordoma, Craniopharyngioma, Glioblastoma, Glioma, Meningioma, Neoplasms, Germ Cell and Embryonal, Oligodendroglioma, Pituitary Neoplasms, Germinoma, Optic Nerve Glioma

NCT02782754 2016-05-25

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Phase 2 Unknown

40 enrolled

Germinoma

Clinical Trials

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

GERMAN

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma